Singapore approves molnupiravir, second oral antiviral drug allowed for treatment of COVID-19 - CNA

More clinics will also be allowed to prescribe Pfizer's Paxlovid, the first pill that was approved.

SINGAPORE: The antiviral drug molnupravir will be the second oral medicine approved in Singapore for the treatment of adult COVID-19 patients, said the Health Sciences Authority (HSA) on Tuesday (Apr… [+2934 chars]

full article...